Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Saxena

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled TrialJoan T Merrill, Yoshiya Tanaka, David D'Cruz, et al.
Journal of the American College of Cardiology|July 18, 2020
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive MothersPeter Izmirly, Mimi Kim, Deborah M Friedman, et al.
The New England Journal of Medicine|September 16, 2020
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, Frédéric Houssiau, et al.
Clinical Pharmacology and Therapeutics|August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19Peter Chen, Gourab Datta, Ying Grace Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus ErythematosusEllen Ginzler, Luiz Sergio Guedes Barbosa, David D'Cruz, et al.
The Lancet. Rheumatology|July 20, 2022
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York CityAmit Saxena, Alexis J Engel, Brittany Banbury, et al.
Anesthesia and Analgesia|June 15, 2021
Expert Consensus Statement on the Perioperative Management of Adult Patients Undergoing Head and Neck Surgery and Free Tissue Reconstruction From the Society for Head and Neck AnesthesiaDavid W Healy, Benjamin H Cloyd, Tracey Straker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
The Lancet. Rheumatology|June 2, 2021
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohortAmit Saxena, Allison Guttmann, Mala Masson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2024
Efficacy and Safety of Upadacitinib or Elsubrutinib Alone or in Combination for Patients With Systemic Lupus Erythematosus: A Phase 2 Randomized Controlled TrialJoan T Merrill, Yoshiya Tanaka, David D'Cruz, et al.
Journal of the American College of Cardiology|July 18, 2020
Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive MothersPeter Izmirly, Mimi Kim, Deborah M Friedman, et al.
The New England Journal of Medicine|September 16, 2020
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus NephritisRichard Furie, Brad H Rovin, Frédéric Houssiau, et al.
Clinical Pharmacology and Therapeutics|August 29, 2021
First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19Peter Chen, Gourab Datta, Ying Grace Li, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2021
Phase III/IV, Randomized, Fifty-Two-Week Study of the Efficacy and Safety of Belimumab in Patients of Black African Ancestry With Systemic Lupus ErythematosusEllen Ginzler, Luiz Sergio Guedes Barbosa, David D'Cruz, et al.
The Lancet. Rheumatology|July 20, 2022
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York CityAmit Saxena, Alexis J Engel, Brittany Banbury, et al.
Anesthesia and Analgesia|June 15, 2021
Expert Consensus Statement on the Perioperative Management of Adult Patients Undergoing Head and Neck Surgery and Free Tissue Reconstruction From the Society for Head and Neck AnesthesiaDavid W Healy, Benjamin H Cloyd, Tracey Straker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2020
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus ErythematosusRuth Fernandez-Ruiz, Mala Masson, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 19, 2023
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical TrialAmit Saxena, Ellen M Ginzler, Keisha Gibson, et al.
Pageof 15